Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (125)	11/6/1998 9:27:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1475

Sam: Making organs out of stem cells is science fiction. It won't happen until and if cloned humans are used as organ farms, and then it would only be used as BTRN thinks about pigs.... to engineer the embryo. And I'd be ther first to shout "unethical". Never going to happen in my kids' lifespans. It (human ES cells) is an advance that will allow for artificial organs, perhaps, in some instances...... pancreas, for example. The applications here may be very valuable. Seeding a failing organ with stem cells? I don't think so. So, what effect will it have? If ENMD is going to open at $20, BTRN will open at $1,400. I'd recommend that you sell when it does such. ;-) Rick